US5536475A
(en)
*
|
1988-10-11 |
1996-07-16 |
Baxter International Inc. |
Apparatus for magnetic cell separation
|
WO1994011078A1
(en)
*
|
1992-11-16 |
1994-05-26 |
Immunivest Corporation |
Magnetic immobilization and manipulation of biological entities
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US6013532A
(en)
*
|
1990-09-26 |
2000-01-11 |
Immunivest Corporation |
Methods for magnetic immobilization and manipulation of cells
|
US5200084A
(en)
*
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
US5466574A
(en)
*
|
1991-03-25 |
1995-11-14 |
Immunivest Corporation |
Apparatus and methods for magnetic separation featuring external magnetic means
|
AU2593192A
(en)
*
|
1992-09-14 |
1994-04-12 |
Oystein Fodstad |
Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
|
FI930440A0
(fi)
|
1993-02-01 |
1993-02-01 |
Labsystems Oy |
Bestaemningsfoerfarande
|
EP0681700B1
(de)
|
1993-02-01 |
2001-11-21 |
Thermo Labsystems Oy |
Verfahren für einen spezifischen Bindungstest mit magnetischen Teilchen
|
FI932866A0
(fi)
*
|
1993-06-21 |
1993-06-21 |
Labsystems Oy |
Separeringsfoerfarande
|
NO180658C
(no)
*
|
1994-03-10 |
1997-05-21 |
Oeystein Fodstad |
Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
|
JP3115501B2
(ja)
*
|
1994-06-15 |
2000-12-11 |
プレシジョン・システム・サイエンス株式会社 |
分注機を利用した磁性体の脱着制御方法及びこの方法によって処理される各種装置
|
DE4421058A1
(de)
|
1994-06-16 |
1995-12-21 |
Boehringer Mannheim Gmbh |
Verfahren zur magnetischen Abtrennung von Flüssigkeitskomponenten
|
DE4423878A1
(de)
*
|
1994-07-07 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Vorrichtung und Verfahren zum Abscheiden von magnetischen Mikropartikeln
|
EP0722087B1
(de)
*
|
1994-07-29 |
2005-06-29 |
Mitsubishi Kagaku Iatron, Inc. |
Mess-system unter verwendung von vollblut
|
US5871625A
(en)
*
|
1994-08-25 |
1999-02-16 |
University Of Iowa Research Foundation |
Magnetic composites for improved electrolysis
|
NO180167C
(no)
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
US5567326A
(en)
*
|
1994-09-19 |
1996-10-22 |
Promega Corporation |
Multisample magnetic separation device
|
US5646263A
(en)
*
|
1994-09-19 |
1997-07-08 |
Promega Corporation |
High efficiency method for isolating target substances using a multisample separation device
|
US5693784A
(en)
*
|
1994-09-19 |
1997-12-02 |
Promega Corporation |
Methods for creating agglomerates from colloidal particles
|
FI944938A0
(fi)
*
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Foerflyttningsanordning
|
FI944940A0
(fi)
*
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Tvaofasigt separeringsfoerfarande
|
FI944939A0
(fi)
*
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Foerfarande foer separering av partiklar
|
FI944937A0
(fi)
|
1994-10-20 |
1994-10-20 |
Labsystems Oy |
Separeringsanordning
|
US5750339A
(en)
*
|
1994-11-30 |
1998-05-12 |
Thomas Jefferson University |
Methods for identifying fetal cells
|
US5628407A
(en)
*
|
1994-12-05 |
1997-05-13 |
Bolt Beranek And Newman, Inc. |
Method and apparatus for separation of magnetically responsive spheres
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
JP3630493B2
(ja)
*
|
1995-03-20 |
2005-03-16 |
プレシジョン・システム・サイエンス株式会社 |
分注機を利用した液体処理方法およびその装置
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
US5660990A
(en)
*
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
NO961031D0
(no)
|
1996-03-13 |
1996-03-13 |
Det Norske Radiumshospital Tum |
Fremgangsmåte til å drepe uönskede målceller
|
US6143578A
(en)
*
|
1996-05-10 |
2000-11-07 |
Bayer Corporation |
Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
|
US5888835A
(en)
*
|
1996-05-10 |
1999-03-30 |
Chiron Diagnostics Corporation |
Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology
|
US6790366B2
(en)
*
|
1996-06-07 |
2004-09-14 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US5993665A
(en)
*
|
1996-06-07 |
1999-11-30 |
Immunivest Corporation |
Quantitative cell analysis methods employing magnetic separation
|
US6660159B1
(en)
|
1996-06-07 |
2003-12-09 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6890426B2
(en)
*
|
1996-06-07 |
2005-05-10 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US7666308B2
(en)
*
|
1996-06-07 |
2010-02-23 |
Veridex, Llc. |
Magnetic separation apparatus and methods
|
US6136182A
(en)
*
|
1996-06-07 |
2000-10-24 |
Immunivest Corporation |
Magnetic devices and sample chambers for examination and manipulation of cells
|
US5795784A
(en)
|
1996-09-19 |
1998-08-18 |
Abbott Laboratories |
Method of performing a process for determining an item of interest in a sample
|
US5856194A
(en)
|
1996-09-19 |
1999-01-05 |
Abbott Laboratories |
Method for determination of item of interest in a sample
|
US6623983B1
(en)
*
|
1997-03-25 |
2003-09-23 |
Immunivest Corporation |
Apparatus and methods for capture and analysis of particulate entities
|
DE69834527T2
(de)
*
|
1997-07-01 |
2007-05-10 |
VLP Watertown Limited Partnership, Watertown |
Verfahren zur Geschlechtsbestimmung von Säuger-Nachkommenschaft
|
JP2002503814A
(ja)
|
1998-02-12 |
2002-02-05 |
イムニベスト・コーポレイション |
循環ガン細胞の迅速かつ効率的な単離のための方法および試薬
|
EP0941766B1
(de)
*
|
1998-03-12 |
2006-12-20 |
Miltenyi Biotec GmbH |
Mikrokolonnen-System für Magnettrennung
|
US6361749B1
(en)
*
|
1998-08-18 |
2002-03-26 |
Immunivest Corporation |
Apparatus and methods for magnetic separation
|
US6150182A
(en)
*
|
1998-11-30 |
2000-11-21 |
Cassaday; Michael M. |
Method for separation of components in a biochemical reaction utilizing a combination of magnetic and centrifugal processes
|
US7364921B1
(en)
|
1999-01-06 |
2008-04-29 |
University Of Medicine And Dentistry Of New Jersey |
Method and apparatus for separating biological materials and other substances
|
WO2000040947A1
(en)
*
|
1999-01-06 |
2000-07-13 |
University Of Medicine And Dentistry Of New Jersey |
Method and apparatus for separating biological materials and other substances
|
US6159378A
(en)
*
|
1999-02-23 |
2000-12-12 |
Battelle Memorial Institute |
Apparatus and method for handling magnetic particles in a fluid
|
EP1177424A4
(de)
*
|
1999-04-09 |
2005-04-06 |
Shot Inc |
Elektromagnetisches mehrphasen-trenngerät zur reinigung von zellen, chemikalien und protein-strukturen
|
US20040058401A1
(en)
*
|
1999-04-13 |
2004-03-25 |
Blaise Bossy |
Method for detecting rare event
|
US6623982B1
(en)
*
|
1999-07-12 |
2003-09-23 |
Immunivest Corporation |
Increased separation efficiency via controlled aggregation of magnetic nanoparticles
|
DE19938372A1
(de)
*
|
1999-08-09 |
2001-03-08 |
Diagnostikforschung Inst |
Verfahren und Vorrichtung zur Trennung magnetischer Teilchen
|
JP4612982B2
(ja)
|
1999-09-03 |
2011-01-12 |
ミルテニィ バイオテック ゲーエムベーハー |
磁性細胞分離カラムにおける選択された細胞の改変方法
|
US20040009486A1
(en)
*
|
1999-10-29 |
2004-01-15 |
Sorge Joseph A. |
Compositions and methods utilizing DNA polymerases
|
WO2001051668A1
(en)
*
|
2000-01-13 |
2001-07-19 |
Immunivest Corporation |
Ferrofluid based arrays
|
US6672458B2
(en)
*
|
2000-05-19 |
2004-01-06 |
Becton, Dickinson And Company |
System and method for manipulating magnetically responsive particles fluid samples to collect DNA or RNA from a sample
|
DK1311820T3
(en)
*
|
2000-07-14 |
2015-04-07 |
Janssen Diagnostics Llc |
Increased separation efficiency via a controlled aggregation of magnetic nanoparticles
|
US20020100582A1
(en)
*
|
2000-09-05 |
2002-08-01 |
Oldenburg Kevin R. |
Rapid thermal cycling device
|
CA2389819A1
(en)
*
|
2000-09-05 |
2002-03-14 |
Kawasaki Steel Corporation |
Magnetic filter apparatus
|
BR0114757A
(pt)
*
|
2000-10-19 |
2003-10-07 |
Tibotec Bvba |
Método e dispositivo para a manipulação de microveìculos com a finalidade de identificação
|
DE10057396C1
(de)
*
|
2000-11-18 |
2002-04-04 |
Karlsruhe Forschzent |
Verfahren zum Abtrennen eines dispergierten oder gelösten Stoffes und Magnetseparator
|
US20020164659A1
(en)
*
|
2000-11-30 |
2002-11-07 |
Rao Galla Chandra |
Analytical methods and compositions
|
CN1502089A
(zh)
*
|
2001-01-05 |
2004-06-02 |
|
对象成像的设备和方法
|
US20020166760A1
(en)
*
|
2001-05-11 |
2002-11-14 |
Prentiss Mara G. |
Micromagentic systems and methods for microfluidics
|
US7132275B2
(en)
*
|
2001-05-14 |
2006-11-07 |
The John Hopkins University |
Multifunctional magnetic nanowires
|
DE10127069A1
(de)
*
|
2001-05-23 |
2002-11-28 |
Bio Medical Apherese Systeme G |
Magnetfilter zur Abtrennung von strömenden magnetischen Objekten
|
US7169578B2
(en)
*
|
2001-07-27 |
2007-01-30 |
Surface Logix, Inc. |
Cell isolation and screening device and method of using same
|
US7169577B2
(en)
*
|
2001-07-27 |
2007-01-30 |
Surface Logix, Inc. |
Cell isolation and screening device and method of using same
|
US7285412B2
(en)
*
|
2001-07-27 |
2007-10-23 |
Surface Logix Inc. |
Device for magnetic immobilization of cells
|
US7863012B2
(en)
*
|
2004-02-17 |
2011-01-04 |
Veridex, Llc |
Analysis of circulating tumor cells, fragments, and debris
|
US20030095897A1
(en)
*
|
2001-08-31 |
2003-05-22 |
Grate Jay W. |
Flow-controlled magnetic particle manipulation
|
US8980568B2
(en)
|
2001-10-11 |
2015-03-17 |
Aviva Biosciences Corporation |
Methods and compositions for detecting non-hematopoietic cells from a blood sample
|
US8986944B2
(en)
|
2001-10-11 |
2015-03-24 |
Aviva Biosciences Corporation |
Methods and compositions for separating rare cells from fluid samples
|
AU2002359648A1
(en)
*
|
2001-12-07 |
2003-06-23 |
Dyax Corporation |
Method and apparatus for washing magnetically responsive particles
|
US7098041B2
(en)
|
2001-12-11 |
2006-08-29 |
Kimberly-Clark Worldwide, Inc. |
Methods to view and analyze the results from diffraction-based diagnostics
|
US7102752B2
(en)
*
|
2001-12-11 |
2006-09-05 |
Kimberly-Clark Worldwide, Inc. |
Systems to view and analyze the results from diffraction-based diagnostics
|
US20030119057A1
(en)
*
|
2001-12-20 |
2003-06-26 |
Board Of Regents |
Forming and modifying dielectrically-engineered microparticles
|
US20030119203A1
(en)
*
|
2001-12-24 |
2003-06-26 |
Kimberly-Clark Worldwide, Inc. |
Lateral flow assay devices and methods for conducting assays
|
US8367013B2
(en)
*
|
2001-12-24 |
2013-02-05 |
Kimberly-Clark Worldwide, Inc. |
Reading device, method, and system for conducting lateral flow assays
|
US7373968B2
(en)
*
|
2002-01-08 |
2008-05-20 |
Kevin R. Oldenburg |
Method and apparatus for manipulating an organic liquid sample
|
US7514270B2
(en)
*
|
2002-04-12 |
2009-04-07 |
Instrumentation Laboratory Company |
Immunoassay probe
|
WO2004039830A2
(en)
*
|
2002-05-07 |
2004-05-13 |
Regents Of The University Of California |
Bioactivation of particles
|
GB0215185D0
(en)
*
|
2002-07-01 |
2002-08-07 |
Genovision As |
Binding a target substance
|
US7314763B2
(en)
*
|
2002-08-27 |
2008-01-01 |
Kimberly-Clark Worldwide, Inc. |
Fluidics-based assay devices
|
US7285424B2
(en)
*
|
2002-08-27 |
2007-10-23 |
Kimberly-Clark Worldwide, Inc. |
Membrane-based assay devices
|
US7432105B2
(en)
*
|
2002-08-27 |
2008-10-07 |
Kimberly-Clark Worldwide, Inc. |
Self-calibration system for a magnetic binding assay
|
US7781172B2
(en)
*
|
2003-11-21 |
2010-08-24 |
Kimberly-Clark Worldwide, Inc. |
Method for extending the dynamic detection range of assay devices
|
US20040106190A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Kimberly-Clark Worldwide, Inc. |
Flow-through assay devices
|
US7247500B2
(en)
*
|
2002-12-19 |
2007-07-24 |
Kimberly-Clark Worldwide, Inc. |
Reduction of the hook effect in membrane-based assay devices
|
US20040142384A1
(en)
*
|
2003-01-16 |
2004-07-22 |
Cohen Barb Ariel |
Magnetic separator
|
US20040157219A1
(en)
*
|
2003-02-06 |
2004-08-12 |
Jianrong Lou |
Chemical treatment of biological samples for nucleic acid extraction and kits therefor
|
US7851209B2
(en)
*
|
2003-04-03 |
2010-12-14 |
Kimberly-Clark Worldwide, Inc. |
Reduction of the hook effect in assay devices
|
US20040197819A1
(en)
*
|
2003-04-03 |
2004-10-07 |
Kimberly-Clark Worldwide, Inc. |
Assay devices that utilize hollow particles
|
US7282180B2
(en)
*
|
2003-07-02 |
2007-10-16 |
Immunivest Corporation |
Devices and methods to image objects
|
US7527741B2
(en)
*
|
2003-07-24 |
2009-05-05 |
Ryoichi Aogaki |
Microreactor including magnetic barrier
|
US7956175B2
(en)
|
2003-09-11 |
2011-06-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of bacteria
|
AU2003285133A1
(en)
*
|
2003-11-05 |
2005-06-24 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Biofunctionalized quantum dots for biological imaging
|
US7713748B2
(en)
*
|
2003-11-21 |
2010-05-11 |
Kimberly-Clark Worldwide, Inc. |
Method of reducing the sensitivity of assay devices
|
US20050112703A1
(en)
|
2003-11-21 |
2005-05-26 |
Kimberly-Clark Worldwide, Inc. |
Membrane-based lateral flow assay devices that utilize phosphorescent detection
|
US7943395B2
(en)
*
|
2003-11-21 |
2011-05-17 |
Kimberly-Clark Worldwide, Inc. |
Extension of the dynamic detection range of assay devices
|
US20050136550A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Kimberly-Clark Worldwide, Inc. |
Flow control of electrochemical-based assay devices
|
US7943089B2
(en)
*
|
2003-12-19 |
2011-05-17 |
Kimberly-Clark Worldwide, Inc. |
Laminated assay devices
|
AU2004237844B2
(en)
|
2003-12-23 |
2011-01-27 |
Therakos, Inc. |
Extracorporeal photopheresis in combination with anti-TNF treatment
|
WO2005065267A2
(en)
*
|
2003-12-24 |
2005-07-21 |
Massachusetts Institute Of Technology |
Magnetophoretic cell clarification
|
WO2005072855A1
(en)
|
2004-01-28 |
2005-08-11 |
Drexel University |
Magnetic fluid manipulators and methods for their use
|
EP1718967B1
(de)
|
2004-02-03 |
2013-04-24 |
Diadexus, Inc. |
Verfahren zum nachweis von lp-pla2-aktivität
|
US7255787B2
(en)
*
|
2004-02-14 |
2007-08-14 |
Aaron Bush |
Device and method for increasing viability in cell types
|
US20050181353A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Rao Galla C. |
Stabilization of cells and biological specimens for analysis
|
US20050239091A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Collis Matthew P |
Extraction of nucleic acids using small diameter magnetically-responsive particles
|
US8211386B2
(en)
*
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
WO2006093516A2
(en)
*
|
2004-06-22 |
2006-09-08 |
The Regents Of The University Of California |
Peptide-coated nanoparticles with graded shell compositions
|
US7094528B2
(en)
*
|
2004-06-30 |
2006-08-22 |
Kimberly-Clark Worldwide, Inc. |
Magnetic enzyme detection techniques
|
US7906276B2
(en)
*
|
2004-06-30 |
2011-03-15 |
Kimberly-Clark Worldwide, Inc. |
Enzymatic detection techniques
|
US7521226B2
(en)
*
|
2004-06-30 |
2009-04-21 |
Kimberly-Clark Worldwide, Inc. |
One-step enzymatic and amine detection technique
|
US20060024204A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Oldenburg Kevin R |
Well plate sealing apparatus and method
|
US20060024776A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Mcmillian Ray |
Magnetic particle capture of whole intact organisms from clinical samples
|
WO2006017427A1
(en)
*
|
2004-08-03 |
2006-02-16 |
Becton, Dickinson And Company |
Use of magnetic material to fractionate samples
|
WO2006017428A2
(en)
*
|
2004-08-03 |
2006-02-16 |
Becton, Dickinson And Company |
Use of magnetic material to direct isolation of compounds and fractionation of multipart samples
|
JP2006281133A
(ja)
*
|
2005-04-01 |
2006-10-19 |
Tokyo Institute Of Technology |
磁気ビーズセパレータ
|
US7749445B2
(en)
*
|
2005-05-02 |
2010-07-06 |
Bioscale, Inc. |
Method and apparatus for analyzing bioprocess fluids
|
US7648844B2
(en)
*
|
2005-05-02 |
2010-01-19 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using an acoustic device
|
US7300631B2
(en)
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
US7611908B2
(en)
*
|
2005-05-02 |
2009-11-03 |
Bioscale, Inc. |
Method and apparatus for therapeutic drug monitoring using an acoustic device
|
US7901950B2
(en)
*
|
2005-08-12 |
2011-03-08 |
Veridex, Llc |
Method for assessing disease states by profile analysis of isolated circulating endothelial cells
|
US9169461B2
(en)
|
2005-11-02 |
2015-10-27 |
Therakos, Inc. |
Use of apoptotic cells ex vivo to generate regulatory T cells
|
CA2652027C
(en)
*
|
2006-05-12 |
2017-06-06 |
Immunivest Corporation |
A laser illumination system in fluorescent microscopy
|
CN101600966B
(zh)
*
|
2006-06-02 |
2014-07-02 |
辉瑞产品公司 |
循环肿瘤细胞分析
|
CN101583722A
(zh)
*
|
2006-07-14 |
2009-11-18 |
阿维瓦生物科学股份有限公司 |
从生物学样品检测稀有细胞的方法和组合物
|
WO2008044311A1
(fr)
*
|
2006-10-13 |
2008-04-17 |
Olympus Corporation |
Procédé d'identification d'état anormal, analyseur, et réactif
|
US8202491B2
(en)
*
|
2006-11-21 |
2012-06-19 |
Bioscale, Inc. |
Apparatus for analyte processing
|
US20080118402A1
(en)
*
|
2006-11-21 |
2008-05-22 |
David Brancazio |
Method and apparatus for analyte processing
|
DK2171098T3
(en)
*
|
2007-06-29 |
2018-05-22 |
Becton Dickinson Co |
PROCEDURES FOR EXTRACTION AND CLEANING COMPONENTS IN BIOLOGICAL SAMPLES
|
US8268177B2
(en)
|
2007-08-13 |
2012-09-18 |
Agency For Science, Technology And Research |
Microfluidic separation system
|
US8354280B2
(en)
*
|
2007-09-06 |
2013-01-15 |
Bioscale, Inc. |
Reusable detection surfaces and methods of using same
|
DE102007043281A1
(de)
|
2007-09-11 |
2009-05-28 |
Sebastian Dr. med. Chakrit Bhakdi |
Vorrichtung, Materialien und Verfahren zur Hochgradientenmagnetseparation biologischen Materials
|
EP2205360A2
(de)
*
|
2007-10-29 |
2010-07-14 |
Philips Intellectual Property & Standards GmbH |
Separatorsäule, separatorsystem, verfahren zur fraktionierung magnetischer partikel, verfahren zur herstellung einer separatorsäule und verwendung einer separatorsäule
|
SI2229591T1
(sl)
|
2007-12-05 |
2012-12-31 |
Zyomyx, Inc. |
Oprema za analizo celic in postopek
|
ES2640216T3
(es)
|
2007-12-07 |
2017-11-02 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
US8071395B2
(en)
*
|
2007-12-12 |
2011-12-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and apparatus for magnetic separation of cells
|
KR101384142B1
(ko)
*
|
2007-12-28 |
2014-04-14 |
삼성디스플레이 주식회사 |
표시기판, 이의 제조방법 및 이를 갖는 표시장치
|
US8556843B2
(en)
*
|
2008-02-02 |
2013-10-15 |
AccelDx |
Blood purification method and apparatus for the treatment of malaria
|
WO2009117611A2
(en)
*
|
2008-03-19 |
2009-09-24 |
Cynvenio Biosystems, Llc |
Trapping magnetic cell sorting system
|
EP2271919A1
(de)
*
|
2008-04-16 |
2011-01-12 |
Cynvenio Biosystems, Inc. |
Magnetisches trennsystem mit vor- und nachbearbeitungsmodulen
|
EP2285493A2
(de)
|
2008-06-09 |
2011-02-23 |
QIAGEN Gaithersburg, Inc. |
Magnetische mikroplattenanordnung
|
US8148163B2
(en)
|
2008-09-16 |
2012-04-03 |
Ibis Biosciences, Inc. |
Sample processing units, systems, and related methods
|
WO2010056337A2
(en)
|
2008-11-12 |
2010-05-20 |
Caris Mpi, Inc. |
Methods and systems of using exosomes for determining phenotypes
|
EP2359164A4
(de)
*
|
2008-12-10 |
2012-05-30 |
Abqmr Inc |
Kernmagnetresonanzgerät, verfahren und zugehörige technologie
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
CN105618264B
(zh)
|
2009-05-15 |
2021-04-06 |
简·探针公司 |
用于在执行磁性分离工序的仪器中实现磁体的自动移动的方法和设备
|
DK2440941T3
(en)
*
|
2009-06-10 |
2017-08-28 |
Cynvenio Biosystems Inc |
Sheath flow devices and methods
|
WO2011007310A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Koninklijke Philips Electronics N.V. |
Apparatus for the enrichment of magnetic particles
|
IN2012DN03194A
(de)
|
2009-10-28 |
2015-10-09 |
Magnetation Inc |
|
GB2476825B
(en)
*
|
2010-01-12 |
2011-12-07 |
Eclipse Magnetics Ltd |
Magnetic filtration apparatus
|
US20140148348A1
(en)
|
2010-01-13 |
2014-05-29 |
Christine Kuslich |
Dectection of gastrointestinal disorders
|
JP5808349B2
(ja)
|
2010-03-01 |
2015-11-10 |
カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー |
セラノーシスのためのバイオマーカー
|
BR112012025593A2
(pt)
|
2010-04-06 |
2019-06-25 |
Caris Life Sciences Luxembourg Holdings |
biomarcadores em circulação para doença
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US9428547B2
(en)
|
2010-04-21 |
2016-08-30 |
Dna Electronics, Inc. |
Compositions for isolating a target analyte from a heterogeneous sample
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
JP2014515694A
(ja)
|
2011-03-11 |
2014-07-03 |
ギーシェン ヤン、 |
磁性粒子スカベンジング装置および方法
|
AU2012245294B2
(en)
|
2011-04-20 |
2015-10-29 |
Magglobal, Llc |
Iron ore separation device
|
US9885642B2
(en)
|
2011-04-27 |
2018-02-06 |
Becton, Dickinson And Company |
Devices and methods for separating magnetically labeled moieties in a sample
|
WO2013006774A1
(en)
|
2011-07-07 |
2013-01-10 |
Veridex, Llc |
Genomic diagnostics using circulating endothelial cells
|
FR2986617B1
(fr)
*
|
2012-02-02 |
2015-03-27 |
Horiba Abx Sas |
Dispositif et procede pour effectuer des mesures hematologiques et biochimiques a partir d'un echantillon biologique
|
IN2014DN06822A
(de)
*
|
2012-08-31 |
2015-05-22 |
Toshiba Kk |
|
ES2912033T3
(es)
|
2012-10-23 |
2022-05-24 |
Caris Science Inc |
Aptámeros y usos de los mismos
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
CN110595987A
(zh)
|
2012-10-26 |
2019-12-20 |
贝克顿·迪金森公司 |
用于操纵流体样品中的组分的装置和方法
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
EP2935628B1
(de)
|
2012-12-19 |
2018-03-21 |
Caris Life Sciences Switzerland Holdings GmbH |
Zusammensetzungen und verfahren für aptamer-screening
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
US20150233932A1
(en)
*
|
2013-02-19 |
2015-08-20 |
Ching-Ping Tseng |
Methods, Systems, and Compositions for Enrichment of Rare Cells
|
US20140242603A1
(en)
*
|
2013-02-26 |
2014-08-28 |
Glenn Yaguang Deng |
Methods and apparatus for target cell magnetic enrichment, isolation and biological analysis
|
US9128017B2
(en)
|
2013-03-19 |
2015-09-08 |
Rarecyte, Inc. |
Device, systems and methods for analyzing a target analyte
|
KR20160080815A
(ko)
|
2013-08-28 |
2016-07-08 |
카리스 라이프 사이언스 스위스 홀딩스 게엠베하 |
올리고뉴클레오티드 프로브 및 이의 용도
|
EP3043904B1
(de)
|
2013-09-09 |
2017-12-27 |
Lab-on-a-Bead AB |
Magnetische partikel zur auftrennung und analyse von molekülen und zellen, sowie verfahren zur herstellung solcher partikel
|
CN113046312A
(zh)
|
2014-04-23 |
2021-06-29 |
朱诺治疗学股份有限公司 |
分离、培养和遗传工程改造用于过继治疗的免疫细胞群的方法
|
MA40253A
(fr)
|
2014-07-15 |
2017-05-24 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
ES2879612T3
(es)
|
2014-10-20 |
2021-11-22 |
Juno Therapeutics Inc |
Métodos y composiciones para dosificación en terapia celular adoptiva
|
MA40318A
(fr)
|
2014-11-05 |
2017-09-13 |
Juno Therapeutics Inc |
Procédés de transduction et de traitement de cellules
|
MX2017007138A
(es)
|
2014-12-03 |
2017-08-28 |
Juno Therapeutics Inc |
Metodos y composiciones para terapia celular adoptiva.
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
US20160208018A1
(en)
|
2015-01-16 |
2016-07-21 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for ror1
|
CA2979361A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Method of preparing oligonucleotide libraries
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
CA2986060A1
(en)
|
2015-05-29 |
2016-12-08 |
Valerie Odegard |
Composition and methods for regulating inhibitory interactions in genetically engineered cells
|
WO2017004243A1
(en)
|
2015-06-29 |
2017-01-05 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
WO2017019918A1
(en)
|
2015-07-28 |
2017-02-02 |
Caris Science, Inc. |
Targeted oligonucleotides
|
ES2599056B2
(es)
|
2015-07-31 |
2017-07-07 |
Pablo ALBERTOS SÁNCHEZ |
Dispositivo para ensayar una muestra de células
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
CN116875635A
(zh)
|
2015-10-22 |
2023-10-13 |
朱诺治疗学有限公司 |
用于转导的方法、反应剂盒、反应剂和设备
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
MA43378A
(fr)
|
2015-12-03 |
2018-10-10 |
Juno Therapeutics Inc |
Compositions et méthodes pour la reduction de la réponse immunitaire contre récepteurs d'antigène chimériques
|
AU2016363025B2
(en)
|
2015-12-03 |
2021-04-08 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
MA43377A
(fr)
|
2015-12-04 |
2021-05-19 |
Hutchinson Fred Cancer Res |
Méthodes et compositions liées à la toxicité associée à la thérapie cellulaire
|
CN108601731A
(zh)
|
2015-12-16 |
2018-09-28 |
磨石肿瘤生物技术公司 |
新抗原的鉴别、制造及使用
|
CA3016361C
(en)
|
2016-03-07 |
2024-01-02 |
X-Zell Inc. |
Compositions and methods for identifying rare cells
|
EP3430548A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zur bestimmung der dosierung eines therapeutikums und verwandte behandlungen
|
EP3430549A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zum adaptiven design eines behandlungsplans und ähnlicher behandlungen
|
EP4339288A2
(de)
|
2016-03-18 |
2024-03-20 |
Caris Science, Inc. |
Oligonukleotidsonden und verwendungen davon
|
EP4015536A1
(de)
|
2016-03-22 |
2022-06-22 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Frühinterventionsverfahren zur vermeidung oder verbesserung von toxizität
|
AU2017271579B2
(en)
|
2016-05-25 |
2023-10-19 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
CA3026453A1
(en)
|
2016-06-03 |
2017-12-07 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
CA3028002A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
MX2019001185A
(es)
|
2016-07-29 |
2019-10-21 |
Juno Therapeutics Inc |
Polipeptidos inmunomoduladores y composiciones y metodos relacionados.
|
ES2926513T3
(es)
|
2016-07-29 |
2022-10-26 |
Juno Therapeutics Inc |
Métodos para evaluar la presencia o ausencia de virus competente en replicación
|
CN110088133B
(zh)
|
2016-07-29 |
2023-12-08 |
朱诺治疗学股份有限公司 |
抗独特型抗体及相关方法
|
EP3957997A1
(de)
|
2016-08-26 |
2022-02-23 |
Juno Therapeutics, Inc. |
Verfahren zur zählung von partikeln in einer zellzusammensetzung
|
CA3035829A1
(en)
|
2016-09-12 |
2018-03-15 |
Juno Therapeutics, Inc. |
Perfusion bioreactor bag assemblies
|
CN110139873A
(zh)
|
2016-10-03 |
2019-08-16 |
朱诺治疗学股份有限公司 |
Hpv特异性结合分子
|
US11896615B2
(en)
|
2016-10-13 |
2024-02-13 |
Juno Therapeutics, Inc. |
Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators
|
WO2018085731A2
(en)
|
2016-11-03 |
2018-05-11 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and a btk inhibitor
|
US20190292246A1
(en)
|
2016-11-03 |
2019-09-26 |
Juno Therapeutics, Inc. |
Combination therapy of a cell based therapy and a microglia imhibitor
|
CN110494565A
(zh)
|
2016-12-02 |
2019-11-22 |
朱诺治疗学股份有限公司 |
工程化b细胞及相关组合物和方法
|
MA46995A
(fr)
|
2016-12-03 |
2019-10-09 |
Acerta Pharma Bv |
Méthodes et compositions pour l'utilisation de lymphocytes t thérapeutiques en association avec des inhibiteurs de kinase
|
CA3045508A1
(en)
|
2016-12-03 |
2018-06-07 |
Juno Therapeutics, Inc. |
Methods for modulation of car-t cells
|
US20200078400A1
(en)
|
2016-12-03 |
2020-03-12 |
Juno Therapeutics, Inc. |
Methods for determining car-t cells dosing
|
JP2019536461A
(ja)
|
2016-12-05 |
2019-12-19 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法のための操作細胞の産生
|
AU2018207305A1
(en)
|
2017-01-10 |
2019-07-25 |
Juno Therapeutics, Inc. |
Epigenetic analysis of cell therapy and related methods
|
CN110418802A
(zh)
|
2017-01-20 |
2019-11-05 |
朱诺治疗学有限公司 |
细胞表面缀合物及相关的细胞组合物和方法
|
CA3052779A1
(en)
|
2017-02-17 |
2018-08-23 |
Fred Hutchinson Cancer Research Center |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
BR112019017767A2
(pt)
|
2017-02-27 |
2020-04-07 |
Juno Therapeutics Inc |
composições, artigos de fabricação e métodos relacionados à dosagem em terapia celular
|
AU2018234640B2
(en)
|
2017-03-14 |
2024-03-14 |
Juno Therapeutics, Inc. |
Methods for cryogenic storage
|
WO2018187791A1
(en)
|
2017-04-07 |
2018-10-11 |
Juno Therapeutics, Inc |
Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods
|
AU2018251188A1
(en)
|
2017-04-14 |
2019-10-31 |
Juno Therapeutics, Inc. |
Methods for assessing cell surface glycosylation
|
BR112019022356A2
(pt)
|
2017-04-27 |
2020-05-26 |
Juno Therapeutics Gmbh |
Reagentes de partícula oligoméricos e métodos de uso dos mesmos
|
CA3061945A1
(en)
|
2017-05-01 |
2018-11-08 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and an immunomodulatory compound
|
MA48781A
(fr)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics Inc |
Articles de fabrication et procédés liés à la toxicité associée à la thérapie cellulaire
|
WO2018223101A1
(en)
|
2017-06-02 |
2018-12-06 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
JP2020526194A
(ja)
|
2017-06-29 |
2020-08-31 |
ジュノー セラピューティクス インコーポレイテッド |
免疫療法薬と関連する毒性を評価するためのマウスモデル
|
BR112020001719A2
(pt)
|
2017-07-29 |
2020-07-21 |
Juno Therapeutics Inc |
reagentes para expansão de células que expressam receptores recombinantes
|
ES2959953T3
(es)
|
2017-08-09 |
2024-02-29 |
Juno Therapeutics Inc |
Métodos para producir composiciones celulares genéticamente modificadas y composiciones relacionadas
|
BR112020001601A2
(pt)
|
2017-08-09 |
2020-08-11 |
Juno Therapeutics Inc |
métodos e composições para preparar células geneticamente manipuladas
|
MA50057A
(fr)
|
2017-09-01 |
2020-07-08 |
Juno Therapeutics Inc |
Expression génique et évaluation d'un risque de développement d'une toxicité suite à une thérapie cellulaire
|
WO2019051335A1
(en)
|
2017-09-07 |
2019-03-14 |
Juno Therapeutics, Inc. |
METHODS OF IDENTIFYING CELLULAR CHARACTERISTICS RELATED TO RESPONSES ASSOCIATED WITH CELL THERAPY
|
CA3080546A1
(en)
|
2017-10-03 |
2019-04-11 |
Juno Therapeutics, Inc. |
Hpv-specific binding molecules
|
KR20200087143A
(ko)
|
2017-10-10 |
2020-07-20 |
그릿스톤 온콜로지, 인코포레이티드 |
핫스팟을 이용한 신생항원 동정
|
SG11202003657VA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Process for producing a t cell composition
|
MA50855A
(fr)
|
2017-11-01 |
2020-09-09 |
Juno Therapeutics Inc |
Procédé de génération de compositions thérapeutiques de cellules modifiées
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
WO2019089848A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
KR20200116077A
(ko)
|
2017-11-01 |
2020-10-08 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B 세포 성숙 항원에 특이적인 키메라 항원 수용체 및 암호화 폴리뉴클레오타이드
|
CA3080904A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
WO2019090364A1
(en)
|
2017-11-06 |
2019-05-09 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and a gamma secretase inhibitor
|
WO2019094835A1
(en)
|
2017-11-10 |
2019-05-16 |
Juno Therapeutics, Inc. |
Closed-system cryogenic vessels
|
CA3083097A1
(en)
|
2017-11-22 |
2019-05-31 |
Gritstone Oncology, Inc. |
Reducing junction epitope presentation for neoantigens
|
CN111989106A
(zh)
|
2017-12-01 |
2020-11-24 |
朱诺治疗学股份有限公司 |
基因工程化细胞的给药和调节方法
|
BR112020011144A2
(pt)
|
2017-12-08 |
2020-11-17 |
Juno Therapeutics Inc |
formulação de meio livre de soro para o cultivo de células e métodos de uso da mesma
|
KR20200109308A
(ko)
|
2017-12-08 |
2020-09-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
세포 요법을 위한 표현형 마커 및 관련 방법
|
MX2020005908A
(es)
|
2017-12-08 |
2020-10-07 |
Juno Therapeutics Inc |
Proceso para producir una composicion de celulas t modificadas.
|
EP3724225A1
(de)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics, Inc. |
Anti-cct5-bindende moleküle und verfahren zur verwendung davon
|
JP7383620B2
(ja)
|
2018-01-31 |
2023-11-20 |
セルジーン コーポレイション |
養子細胞療法およびチェックポイント阻害剤を使用する併用療法
|
JP2021511802A
(ja)
|
2018-01-31 |
2021-05-13 |
ジュノー セラピューティクス インコーポレイテッド |
複製可能ウイルスの存在または非存在を評価するための方法および試薬
|
WO2019169194A1
(en)
|
2018-02-28 |
2019-09-06 |
Juno Therapeutics, Inc. |
Methods for detecting particles present in a cell composition
|
WO2019170845A1
(en)
|
2018-03-09 |
2019-09-12 |
Ospedale San Raffaele S.R.L. |
Il-1 antagonist and toxicity induced by cell therapy
|
CN112566698A
(zh)
|
2018-04-05 |
2021-03-26 |
朱诺治疗学股份有限公司 |
T细胞受体和表达该t细胞受体的工程化细胞
|
EP3775238A1
(de)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von zellen, die einen rekombinanten rezeptor exprimieren, und verwandte zusammensetzungen
|
MX2020010461A
(es)
|
2018-04-05 |
2021-01-15 |
Juno Therapeutics Inc |
Linfocitos t que expresan un receptor recombinante, polinucleotidos y metodos relacionados.
|
CA3098497A1
(en)
|
2018-05-03 |
2019-11-07 |
Juno Therapeutics, Inc. |
Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
|
EP3807305A4
(de)
|
2018-06-13 |
2022-04-20 |
Akron Biotechnology, LLC |
Verfahren zur herstellung von therapeutisch wirksamem aldesleukin, das in flüssigen pharmazeutischen zusammensetzungen hochstabil ist
|
WO2020019001A1
(en)
*
|
2018-07-20 |
2020-01-23 |
Cornell University |
Magnetic separation of biological entities from fluid sample
|
US11278915B1
(en)
|
2018-07-20 |
2022-03-22 |
NeoGeneStar LLC |
Device for capturing and releasing magnetic particles
|
US20210230671A1
(en)
|
2018-08-09 |
2021-07-29 |
Juno Therapeutics, Inc. |
Methods for assessing integrated nucleic acids
|
US20210163893A1
(en)
|
2018-08-09 |
2021-06-03 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
CA3110905A1
(en)
|
2018-08-31 |
2020-03-05 |
Invectys SA |
Chimeric antigen receptors against multiple hla-g isoforms
|
CN113167796A
(zh)
|
2018-09-11 |
2021-07-23 |
朱诺治疗学股份有限公司 |
对工程化细胞组合物进行质谱分析的方法
|
WO2020092854A2
(en)
|
2018-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
|
WO2020092848A2
(en)
|
2018-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Methods for treatment using chimeric antigen receptors specific for b-cell maturation antigen
|
EP3877054B1
(de)
|
2018-11-06 |
2023-11-01 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von genetisch veränderten t-zellen
|
AU2019377854A1
(en)
|
2018-11-08 |
2021-05-27 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and T cell modulation
|
JP2022513062A
(ja)
|
2018-11-16 |
2022-02-07 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞悪性腫瘍を処置するために、操作されたt細胞を投薬する方法
|
MX2021006244A
(es)
|
2018-11-30 |
2021-09-10 |
Juno Therapeutics Inc |
Metodos de dosificacion y tratamiento de canceres de celulas b en terapia celular adoptiva.
|
JP2022513685A
(ja)
|
2018-11-30 |
2022-02-09 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法を用いた処置のための方法
|
PE20212198A1
(es)
|
2019-01-29 |
2021-11-16 |
Juno Therapeutics Inc |
Anticuerpos y receptores quimericos de antigenos especificos para receptor 1 huerfano tipo receptor tirosina-cinasa (ror1)
|
EP3693739A1
(de)
|
2019-02-06 |
2020-08-12 |
Stefan Schreier |
Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien
|
EP3938114B1
(de)
*
|
2019-03-15 |
2024-01-10 |
Siemens Healthcare Diagnostics Inc. |
Verfahren und vorrichtung zur manipulation magnetischer beads
|
AU2020265741A1
(en)
|
2019-05-01 |
2021-11-25 |
Editas Medicine, Inc. |
Cells expressing a recombinant receptor from a modified TGFBR2 Locus, related polynucleotides and methods
|
MX2021013223A
(es)
|
2019-05-01 |
2022-02-17 |
Juno Therapeutics Inc |
Celulas que expresan un receptor quimerico de un locus cd247 modificado, polinucleotidos relacionados y metodos.
|
US20220249637A1
(en)
|
2019-06-12 |
2022-08-11 |
Juno Therapeutics, Inc. |
Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family protein
|
WO2021035194A1
(en)
|
2019-08-22 |
2021-02-25 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
|
WO2021041994A2
(en)
|
2019-08-30 |
2021-03-04 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
US11208682B2
(en)
|
2019-09-13 |
2021-12-28 |
Western Digital Technologies, Inc. |
Enhanced optical detection for nucleic acid sequencing using thermally-dependent fluorophore tags
|
WO2021092097A1
(en)
|
2019-11-05 |
2021-05-14 |
Juno Therapeutics, Inc. |
Methods of determining attributes of therapeutic t cell compositions
|
US20220401483A1
(en)
|
2019-11-07 |
2022-12-22 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and (s)-3-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l-oxo-l,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione
|
US11747329B2
(en)
*
|
2019-11-22 |
2023-09-05 |
Western Digital Technologies, Inc. |
Magnetic gradient concentrator/reluctance detector for molecule detection
|
WO2021113780A1
(en)
|
2019-12-06 |
2021-06-10 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
|
JP2023504737A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞性悪性疾患を処置するための細胞療法と関連する毒性および奏効に関係する方法
|
JP2023504740A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
AU2021209940A1
(en)
|
2020-01-24 |
2022-08-04 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment of follicular lymphoma and marginal zone lymphoma in adoptive cell therapy
|
WO2021154887A1
(en)
|
2020-01-28 |
2021-08-05 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
EP4103204A1
(de)
|
2020-02-12 |
2022-12-21 |
Juno Therapeutics, Inc. |
Cd19-gerichtete chimäre antigen-rezeptor-t-zell-zusammensetzungen und verfahren und verwendungen davon
|
JP2023519099A
(ja)
|
2020-02-12 |
2023-05-10 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用
|
KR20230009386A
(ko)
|
2020-04-10 |
2023-01-17 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B-세포 성숙 항원을 표적화하는 키메라 항원 수용체로 조작된 세포 요법 관련 방법 및 용도
|
EP4142723A2
(de)
|
2020-04-28 |
2023-03-08 |
Juno Therapeutics, Inc. |
Kombination aus bcma-gerichteter t-zelltherapie und einer immunmodulatorischen verbindung
|
KR20230022868A
(ko)
|
2020-05-13 |
2023-02-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 공여자-배치 세포의 제조 방법
|
JP2023528215A
(ja)
|
2020-05-13 |
2023-07-04 |
ジュノー セラピューティクス インコーポレイテッド |
臨床応答に関連する特徴量の特定方法およびその使用
|
WO2021260186A1
(en)
|
2020-06-26 |
2021-12-30 |
Juno Therapeutics Gmbh |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
EP4192868A1
(de)
|
2020-08-05 |
2023-06-14 |
Juno Therapeutics, Inc. |
Antiidiotypische antikörper gegen ror1-gerichtete bindungsdomänen und zugehörige zusammensetzungen und verfahren
|
WO2022098787A1
(en)
|
2020-11-04 |
2022-05-12 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
CN117693508A
(zh)
|
2021-03-03 |
2024-03-12 |
朱诺治疗学股份有限公司 |
T细胞疗法和dgk抑制剂的组合
|
KR20230159851A
(ko)
|
2021-03-22 |
2023-11-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
치료 세포 조성물의 효력을 결정하는 방법
|
WO2022212400A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t cell therapy
|
WO2022212384A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Combination of a car t cell therapy and an immunomodulatory compound for treatment of lymphoma
|
KR20230171468A
(ko)
|
2021-04-16 |
2023-12-20 |
셀진 코포레이션 |
Bcma-지시된 t 세포 요법과의 조합 요법
|
CN113391010B
(zh)
*
|
2021-07-07 |
2023-03-24 |
安图实验仪器(郑州)有限公司 |
临床自动分析仪器的进样方法
|
DE202021105458U1
(de)
|
2021-10-08 |
2023-01-24 |
Sanolibio Co., Ltd. |
Vorrichtung zur magnetischen Aufreinigung biologischer Proben
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
WO2024031091A2
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|